Ribonucleic Acid Interference Technology Market By Application 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Ribonucleic Acid Interference (RNAi) Technology Market
Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)
Report Code : HCR 0373
Published: 06 October, 2016   20% discount on this report

  • Report Description
  • Table of Contents
  • Customization Options
RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics. Globally increasing R&D activities in the field of RNAi activities is expected to be the key growth driver during the period of study.

 Ribonucleic Acid Interference (RNAi) Technology Market

Geographically North America dominated RNAi technology market owing to the large scale of its pharmaceutical industry which invests heavily in R&D activities to formulate and update new therapies. North America was followed by Europe and Asia-Pacific as second and third largest market for RNAi technology market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing pharmaceutical industrial infrastructure which has attracted many global industry player, government initiatives and in developing nations such as China, and India in this region.

This report identifies the global RNAi technology market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global RNAi technology market.

This report segments global RNAi technology market on the basis of application, tools and regional market as follows:
  • RNAi Technology Market research report is classified on the basis of applications of RNAi technology in wide range of industries some of the major applications of RNAi Technology covered in this report are as follows: Research and Development, Therapeutics, Drug Discovery, Agriculture and Others
  • RNAi technology market research report is classified on the basis of tools of RNAi technology in wide range of industries some of the major applications of RNAi technology covered in this report are as follows: Design/Software, Delivery Based, Monitoring, Libraries
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the RNAi technology market. Some of the major companies’ profiles in detail are as follows:
  • F. Hoffmann-La Roche AG
  • Alnylam pharmaceuticals
  • Arrowhead research corporation
  • Quark pharmaceuticals inc
  • Rxi pharmaceuticals corp.
1. RNAi Technology Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. RNAi Technology Market– Market Forces
   4.1. Drivers
      4.1.1. Increasing R&D activities in the field of RNAi
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. RNAi Technology Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. RNAi Technology Market, By Tools
   6.1. Design/Software
   6.2. Delivery Based
   6.3. Monitoring
   6.4. Libraries
   6.5. Others
7. RNAi Technology Market, By Applications
   7.1. Research and Development
   7.2. Therapeutics
   7.3. Drug Discovery
   7.4. Agriculture
   7.5. Others
8. RNAi Technology Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. RNAi Technology Market – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Rosetta Genomics
   10.2. Exiqon A/S
   10.3. Merck KGaA
   10.4. Pfizer Inc.
   10.5. F. Hoffmann-La Roche AG
   10.6. Alnylam pharmaceuticals
   10.7. Arrowhead research corporation
   10.8. Quark pharmaceuticals inc
   10.9. Rxi pharmaceuticals corp.
   10.10. Silence therapeutics
   10.11. Tekmira pharmaceuticals corp
   10.12. Thermo fisher scientific inc
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll